In the US, markets reacted more positively to the easing of US-China trade tensions, which have roiled global supply chains and stirred fears of higher domestic inflation. The S&P 500 index rose for ... ( read original story ...)
Some Chinese companies eye Singapore listings to expand markets amid trade war
At least five Chinese and Hong Kong firms eye listings on SGX. Read more at straitstimes.com. Read more at straitstimes.com. ( read original story ...)
US Stock Market Highlights: S&P 500 marks 5th straight gain, up 5% as China tensions cool
The S&P 500 rose for a fifth straight session on Friday, closing the week up 5.3%, despite weak consumer sentiment data and inflation concerns. The Nasdaq jumped 7.2%, while the Dow gained 3.4%. Tech ... ( read original story ...)
Colombia seeks to join China-based development bank as Latin America drifts away from Washington
Colombia's government has applied to join a China-based development bank, another sign of Latin America's drift away from the U.S. as the Trump administration's foreign aid cuts, trade barriers and ... ( read original story ...)
What’s Nvidia’s Next Move in China?
Nvidia plans to open a research-and-development center in Shanghai, its latest effort to maintain a foothold in China after the Trump administration’s attempts to tighten export controls for its AI ... ( read original story ...)
Nvidia Plans To Expand Presence in China With Shanghai R&D Center, Report Says
KEY TAKEAWAYS Nvidia is reportedly expanding in China, even as the U.S. cracks down on its sale of chips to the country.The Financial Times reported Friday that the U.S. chip firm is building a ... ( read original story ...)
Fierce Pharma Asia—Pfizer partner’s trial win; Roche’s $300M China plant; Hengrui’s HK IPO plan
Pfizer and RemeGen's HER2 antibody-drug conjugate delivered positive phase 3 results in a bladder cancer trial in China. | Pfizer and RemeGen's HER2 ADC delivered positive phase 3 results in a bladder ... ( read original story ...)